Depressed serum erythropoietin in pregnant women with elevated blood lead.

Arch Environ Health

Department of Pharmacology, Columbia University, College of Physicians & Surgeons, New York, New York.

Published: February 1992

During the course of a prospective study of lead exposure and pregnancy outcome in 1,502 women, we tested the hypothesis that environmental lead exposure is associated with depressed serum erythropoietin concentration. At mid-pregnancy and at delivery, blood samples were stratified by hemoglobin concentration; within each hemoglobin stratum, sera of women with the lowest and highest whole blood lead concentrations were selected for serum erythropoietin analysis. Analysis of variance revealed that women with higher blood lead levels had inappropriately low serum erythropoietin at both mid-pregnancy and at delivery. Thus, depressed serum erythropoietin appears to indicate lead nephrotoxicity, and it may also be responsible for the anemia associated with lead poisoning.

Download full-text PDF

Source
http://dx.doi.org/10.1080/00039896.1991.9934401DOI Listing

Publication Analysis

Top Keywords

serum erythropoietin
20
depressed serum
12
blood lead
12
lead exposure
8
mid-pregnancy delivery
8
lead
7
erythropoietin
5
erythropoietin pregnant
4
women
4
pregnant women
4

Similar Publications

Patients with chronic inflammation are burdened with anemia of inflammation (AI), where inflammatory cytokines inhibit erythropoiesis, impede erythropoietin production, and limit iron availability by inducing the iron regulator hepcidin. High hepcidin hinders iron absorption and recycling, thereby worsening the impaired erythropoiesis by restricting iron availability. AI management is important as anemia impacts quality of life and potentially affects morbidity and mortality.

View Article and Find Full Text PDF

Lyophilized powder of calf bone marrow hydrolysate liposomes improved renal anemia: In vitro and in vivo evaluation.

PLoS One

December 2024

Department of Research and Development, Jinan Perfect Biological Technology Co., LTD, Jinan, Shandong, China.

This study aimed to find whether oral administration of calf bone marrow hydrolysate liposomes (CBMHL) can improve renal anemia. Calf bone marrow was defatted, papain hydrolyzed, liposomalized and lyophilized. Its hematopoietic ability was proved by the colony formation experiment of umbilical cord blood hematopoietic stem cells in vitro.

View Article and Find Full Text PDF

Resistance to Epoetin-Stimulating Agents in Children Receiving Renal Replacement Therapy.

Clin Pediatr (Phila)

December 2024

Division of Pediatric Nephrology, Department of Pediatrics, School of Medicine, Marmara University, Istanbul, Turkey.

The incidence of anemia increases with the stage of chronic kidney disease (CKD). Erythropoietin (EPO) deficiency is a common cause of anemia in CKD. Erythropoietin-stimulating agents (ESAs) are the mainstay of the treatment.

View Article and Find Full Text PDF

Anemia and mineral and bone disorder (MBD) are significant complications of chronic kidney disease (CKD). The erythropoietin (Epo) pathway plays a key role in both of these processes in CKD. Another molecule that plays an important role in CKD-MBD is fibroblast growth factor (FGF)-23, whose main role is to maintain serum phosphate levels in the normal range, acting via its co-receptor Klotho; however, its activity may also be related to anemia and inflammation.

View Article and Find Full Text PDF

Background: Nucleated red blood cells (nRBCs) are increased by disease processes and hematopoietic stress.

Objectives: To evaluate the utility of nRBCs as a marker of disease severity and prognosis in dogs with systemic inflammatory response syndrome (SIRS).

Animals: Sixty-two client-owned dogs met the criteria of SIRS without anemia.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!